Cargando…

Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19

The ACE2 gene is a receptor of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) for COVID-19 (coronavirus disease 2019). To analyze the expression profiles and clinical significances for this gene in humans, RNA-seq data representing 27 different tissues were analyzed using NCBI; total R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Jiewen, Zhou, Baixu, Zhang, Lianmei, Balaji, Kyathegowdanadoddi Srinivasa, Wei, Chunli, Liu, Xiaoyan, Chen, Hanchun, Peng, Jiangzhou, Fu, Junjiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224351/ https://www.ncbi.nlm.nih.gov/pubmed/32410141 http://dx.doi.org/10.1007/s11033-020-05478-4

Ejemplares similares

Evaluation and characterization of HSPA5 (GRP78) expression profiles in normal individuals and cancer patients with COVID-19
por: Fu, Jiewen, et al.
Publicado: (2021)

Prostate adenocarcinoma and COVID‐19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS‐CoV‐2
por: Cheng, Jingliang, et al.
Publicado: (2021)

Epigenetic modification and a role for the E3 ligase RNF40 in cancer development and metastasis
por: Fu, Junjiang, et al.
Publicado: (2020)

The Correlation Between Immune Invasion and SARS-COV-2 Entry Protein ADAM17 in Cancer Patients by Bioinformatic Analysis
por: Wang, Kai, et al.
Publicado: (2022)

The regulation of ISG20 expression on SARS-CoV-2 infection in cancer patients and healthy individuals
por: Cheng, Jingliang, et al.
Publicado: (2022)

COVID-19 disease and malignant cancers: The impact for the furin gene expression in susceptibility to SARS-CoV-2
por: Li, Dabing, et al.
Publicado: (2021)

Effect of DPP4/CD26 expression on SARS-CoV-2 susceptibility, immune response, adenosine (derivatives m(6)(2)A and CD) regulations on patients with cancer and healthy individuals
por: Du, Jiaman, et al.
Publicado: (2023)

Identification of a novel germline BRCA2 variant in a Chinese breast cancer family
por: Cheng, Jingliang, et al.
Publicado: (2019)

Impact of TMPRSS2 Expression, Mutation Prognostics, and Small Molecule (CD, AD, TQ, and TQFL12) Inhibition on Pan-Cancer Tumors and Susceptibility to SARS-CoV-2
por: Fu, Jiewen, et al.
Publicado: (2022)

COVID-19 receptor and malignant cancers: Association of CTSL expression with susceptibility to SARS-CoV-2
por: Zhang, Lianmei, et al.
Publicado: (2022)

Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2
por: Fu, Jiewen, et al.
Publicado: (2022)

Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013)

Comprehensive analysis, immune, and cordycepin regulation for SOX9 expression in pan-cancers and the matched healthy tissues
por: Liu, Shuguang, et al.
Publicado: (2023)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
por: Vio, Carlos P., et al.
Publicado: (2020)

A novel missense variant c.G644A (p.G215E) of the RPGR gene in a Chinese family causes X-linked retinitis pigmentosa
por: Fu, Jiewen, et al.
Publicado: (2019)

Angiotensin-Converting Enzyme 2 Expression and Severity of SARS-CoV-2 Infection
por: Alabsi, Sarah, et al.
Publicado: (2023)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2
por: Barker, Harlan, et al.
Publicado: (2020)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Gersh, Felice L.
Publicado: (2020)

Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
por: Bian, Jingwei, et al.
Publicado: (2021)

SARS-CoV-2, the Angiotensin Converting Enzyme 2 (ACE2) Receptor and Alzheimer’s disease
por: Lukiw, Walter J.
Publicado: (2021)

Angiotensin-Converting Enzyme 2: The First Decade
por: Clarke, Nicola E., et al.
Publicado: (2012)

Angiotensin-converting enzyme 2 in lung diseases
por: Kuba, Keiji, et al.
Publicado: (2006)

On the essentiality of the angiotensin converting enzyme 2 receptor for SARS‐CoV‐2 infection and the potential of soluble angiotensin converting enzyme 2 proteins as universal approach for variants causing COVID‐19
por: Hassler, Luise, et al.
Publicado: (2022)

In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

The role and significance of angiotensin‐converting enzyme 2 peptides in the treatment of coronavirus disease 2019
por: Liu, Yang, et al.
Publicado: (2021)

Clinical significance and molecular mechanism of angiotensin-converting enzyme 2 in hepatocellular carcinoma tissues
por: Huang, Wei-Jian, et al.
Publicado: (2021)

Novel, heterozygous, de novo pathogenic variant (c.4963delA: p.Thr1656Glnfs*42) of the NF1 gene in a Chinese family with neurofibromatosis type 1
por: Yang, Lisha, et al.
Publicado: (2023)

Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2
por: Zhao, Xuesen, et al.
Publicado: (2020)

Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2
por: Jiang, Ren-Di, et al.
Publicado: (2020)

Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2
por: Muchtaridi, Muchtaridi, et al.
Publicado: (2020)

Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species
por: Zhang, Hong-Liang, et al.
Publicado: (2021)

A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent
por: Xiao, Tianshu, et al.
Publicado: (2021)

Overexpression of the SARS-CoV-2 receptor angiotensin converting enzyme 2 in cardiomyocytes of failing hearts
por: Vukusic, Kristina, et al.
Publicado: (2022)

Hyperglycemia and Angiotensin-Converting Enzyme 2 in Pulmonary Function in the Context of SARS-CoV-2 Infection
por: Vargas-Rodriguez, Jose R., et al.
Publicado: (2022)

Angiotensin‐Converting Enzyme 2 (SARS‐CoV‐2 receptor) expression in human skeletal muscle
por: Perez‐Valera, Mario, et al.
Publicado: (2021)

Computational optimization of angiotensin-converting enzyme 2 for SARS-CoV-2 Spike molecular recognition
por: Di Rienzo, Lorenzo, et al.
Publicado: (2021)

Carlina oxide inhibits the interaction of SARS-CoV-2 S glycoprotein with angiotensin-converting enzyme 2
por: Wnorowska, Sylwia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vhmv4r87a9bpdkbk7bff3vqcbr